Advertisement

Topics

Amedisys, Inc. Company Profile

15:35 EST 23rd November 2017 | BioPortfolio

Amedisys, Inc. (NASDAQ: AMED) is the nation’s leading health care company focused on bringing home the continuum of care. Each day Amedisys delivers personalized health care services to more than 35,000 individual patients and their families, in the comfort of patients’ homes. Amedisys has two divisions, home health care and hospice, and employs more than 16,000 skilled clinicians across the country. The Company’s state-of-the-art advanced chronic care management programs and leading-edge technology enables it to deliver quality care based upon the latest evidence-based best practices. Amedisys is a recognized innovator, being the first in the industry to equip its clinicians with point-of-care laptop technology and referring physicians with an internet portal that enables real-time coordination of patient care seamlessly. Amedisys also has the industry’s first-ever nationwide Care Transitions program. Amedisys Care Transitions is designed to reduce unnecessary hospital readmissions through patient and caregiver health coaching and care coordination, which starts in the hospital and continues throughout completion of the patient’s home health plan of care. For more information about the Company, please visit: www.amedisys.com.


News Articles [8 Associated News Articles listed on BioPortfolio]

Amedisys, Inc.: Prospects For Future Growth

AMEDISYS Inc 2017 Q3 - Results - Earnings Call Slides

AMEDISYS Inc 2017 Q2 - Results - Earnings Call Slides

Amedisys' (AMED) CEO Paul Kusserow on Q2 2017 Results - Earnings Call Transcript

Amedisys' (AMED) CEO Paul Kusserow on Q3 2017 Results - Earnings Call Transcript

Amedisys Adopts CellTrak’s Care Delivery Management Solution for Its Fast-Expanding Personal Care Division

CellTrak Technologies, provider of the industry’s leading Care Delivery Management solution – used at over 4,000 agency locations – announced an expansion of its 12-year rel...

Amedisys Selects Forcura for Paperless Document Management and Secure Communication

Jacksonville, FL, October 10, 2017 --(PR.com)-- Forcura, a healthcare technology company, announces that Amedisys, Inc., one of the nation’s leading home healthcare, hospice and personal care c...

Amedisys Inc AMED Pharmaceuticals Healthcare Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

SummaryAmedisys Inc Amedisys is a healthcare company that offers home health care, hospice service and personal care. The company provides practical nursing services and occupational therapy, comfort ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Amedisys Inc.

Amedisys, Inc. (NASDAQ: AMED) is a leading health care company focused on bringing home the continuum of care. Amedisys delivers personalized health care services to patients and ...

Amedisys, Inc.

Amedisys, Inc. (NASDAQ: AMED) is the nation’s leading health care company focused on bringing home the continuum of care. Each day Amedisys delivers personalized health care ...

More Information about "Amedisys, Inc." on BioPortfolio

We have published hundreds of Amedisys, Inc. news stories on BioPortfolio along with dozens of Amedisys, Inc. Clinical Trials and PubMed Articles about Amedisys, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amedisys, Inc. Companies in our database. You can also find out about relevant Amedisys, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record